These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Minimal residual disease before and after transplantation for childhood acute lymphoblastic leukaemia: is there any room for intervention? Balduzzi A; Di Maio L; Silvestri D; Songia S; Bonanomi S; Rovelli A; Conter V; Biondi A; Cazzaniga G; Valsecchi MG Br J Haematol; 2014 Feb; 164(3):396-408. PubMed ID: 24422724 [TBL] [Abstract][Full Text] [Related]
28. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group. Cavé H; van der Werff ten Bosch J; Suciu S; Guidal C; Waterkeyn C; Otten J; Bakkus M; Thielemans K; Grandchamp B; Vilmer E N Engl J Med; 1998 Aug; 339(9):591-8. PubMed ID: 9718378 [TBL] [Abstract][Full Text] [Related]
29. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies. Uderzo C; Dini G; Locatelli F; Miniero R; Tamaro P Haematologica; 2000 Nov; 85(11 Suppl):47-53. PubMed ID: 11268324 [TBL] [Abstract][Full Text] [Related]
30. [Acute lymphoblastic leukemia (ALL)]. Imai K; Akiyama H Gan To Kagaku Ryoho; 2007 Dec; 34(13):2180-4. PubMed ID: 18079617 [TBL] [Abstract][Full Text] [Related]
31. Minimal residual disease in childhood acute lymphoblastic leukemia: current status and challenges. Izraeli S; Waldman D Acta Haematol; 2004; 112(1-2):34-9. PubMed ID: 15179003 [TBL] [Abstract][Full Text] [Related]
32. [Monitoring minimal residual disease in pediatric patients with acute lymphoblastic leukemia]. Zuna J; Hrusák O; Kalinová M; Muzíková K; Zörnerová T; Starý J; Trka J Vnitr Lek; 2000 Aug; 46(8):465-9. PubMed ID: 11048511 [TBL] [Abstract][Full Text] [Related]
33. Minimal residual disease directed therapy for childhood acute myeloid leukaemia: the time is now. Goulden N; Virgo P; Grimwade D Br J Haematol; 2006 Aug; 134(3):273-82. PubMed ID: 16848770 [TBL] [Abstract][Full Text] [Related]
34. [Clinical significance of glucocorticoid induction test in Chinese childhood acute lymphoblastic leukemia]. Fan JJ; Chai YH; Hu SY; He HL; Zhao WL; Wang Y; Li J; Lu J; Xiao PF; Sun YN; Wang W; Cao L Zhonghua Er Ke Za Zhi; 2013 Jul; 51(7):523-6. PubMed ID: 24267134 [TBL] [Abstract][Full Text] [Related]
39. Detection of minimal residual disease in leukemia using polymerase chain reaction and restriction analysis. Wu N; Lu S; Zhu P; Liu L; Peng Y Chin Med J (Engl); 1997 Jan; 110(1):73-7. PubMed ID: 9594329 [TBL] [Abstract][Full Text] [Related]
40. Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group. Bader P; Kreyenberg H; Henze GH; Eckert C; Reising M; Willasch A; Barth A; Borkhardt A; Peters C; Handgretinger R; Sykora KW; Holter W; Kabisch H; Klingebiel T; von Stackelberg A; J Clin Oncol; 2009 Jan; 27(3):377-84. PubMed ID: 19064980 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]